GlycoMimetics Valuation
| GLYC Stock | USD 0.24 0.01 4.00% |
GlycoMimetics seems to be undervalued based on Macroaxis valuation methodology. Our model calculates the value of GlycoMimetics from evaluating the firm fundamentals such as Return On Equity of -1.04, return on asset of -0.59, and Shares Owned By Insiders of 3.12 % as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting GlycoMimetics' valuation include:
Price Book 1.3536 | Enterprise Value 1.3 M | Enterprise Value Ebitda (0.48) | Price Sales 1.5 K | Enterprise Value Revenue 126.9238 |
Undervalued
Today
Please note that GlycoMimetics' price fluctuation is out of control at this time. Calculation of the real value of GlycoMimetics is based on 3 months time horizon. Increasing GlycoMimetics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since GlycoMimetics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GlycoMimetics Stock. However, GlycoMimetics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.24 | Real 1.55 | Target 5.5 | Hype 0.32 |
The real value of GlycoMimetics Stock, also known as its intrinsic value, is the underlying worth of GlycoMimetics Company, which is reflected in its stock price. It is based on GlycoMimetics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of GlycoMimetics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of GlycoMimetics helps investors to forecast how GlycoMimetics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GlycoMimetics more accurately as focusing exclusively on GlycoMimetics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use GlycoMimetics' intrinsic value based on its ongoing forecasts of GlycoMimetics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against GlycoMimetics' closest peers. If more than one evaluation category is relevant for GlycoMimetics we suggest using both methods to arrive at a better estimate.
GlycoMimetics Cash |
|
GlycoMimetics Valuation Trend
Comparing GlycoMimetics' enterprise value against its market capitalization is a good way to estimate the value of GlycoMimetics uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
GlycoMimetics Total Value Analysis
GlycoMimetics is currently anticipated to have valuation of 1.27 M with market capitalization of 15.47 M, debt of 808.4 K, and cash on hands of 60.24 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the GlycoMimetics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.27 M | 15.47 M | 808.4 K | 60.24 M |
GlycoMimetics Investor Information
About 48.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.35. Some equities with similar Price to Book (P/B) outperform the market in the long run. GlycoMimetics recorded a loss per share of 0.62. The entity had not issued any dividends in recent years. Based on the key indicators related to GlycoMimetics' liquidity, profitability, solvency, and operating efficiency, GlycoMimetics is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.GlycoMimetics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. GlycoMimetics has an asset utilization ratio of 0.0221 percent. This indicates that the Company is making $2.21E-4 for each dollar of assets. An increasing asset utilization means that GlycoMimetics is more efficient with each dollar of assets it utilizes for everyday operations.GlycoMimetics Ownership Allocation
GlycoMimetics has a total of 64.48 Million outstanding shares. 30% of GlycoMimetics outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.GlycoMimetics Profitability Analysis
The company reported the previous year's revenue of 10 K. Net Loss for the year was (36.9 M) with profit before overhead, payroll, taxes, and interest of 75 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates GlycoMimetics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in GlycoMimetics and how it compares across the competition.
About GlycoMimetics Valuation
The stock valuation mechanism determines GlycoMimetics' current worth on a weekly basis. Our valuation model uses a comparative analysis of GlycoMimetics. We calculate exposure to GlycoMimetics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of GlycoMimetics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 10 K | 9.5 K | |
| Pretax Profit Margin | -3.7 K | -3.5 K | |
| Operating Profit Margin | -3.9 K | -3.7 K | |
| Net Loss | -3.7 K | -3.5 K | |
| Gross Profit Margin | (14.69) | (13.96) |
GlycoMimetics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 63.3 M |
GlycoMimetics Current Valuation Indicators
Valuation refers to the process of determining the present value of GlycoMimetics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value GlycoMimetics we look at many different elements of the entity such as GlycoMimetics's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as GlycoMimetics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use GlycoMimetics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes GlycoMimetics' worth.Complementary Tools for GlycoMimetics Stock analysis
When running GlycoMimetics' price analysis, check to measure GlycoMimetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlycoMimetics is operating at the current time. Most of GlycoMimetics' value examination focuses on studying past and present price action to predict the probability of GlycoMimetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlycoMimetics' price. Additionally, you may evaluate how the addition of GlycoMimetics to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |